Search Results - Michael Noss
- Showing 1 - 1 results of 1
-
1
Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study by Remon Abu-Elyazeed, William Jennings, Randall Severance, Michael Noss, Adrian Caplanusi, Michael Povey, Ouzama Henry
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book